» Authors » Antoine Valeri

Antoine Valeri

Explore the profile of Antoine Valeri including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 81
Citations 2472
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Boussion N, Schick U, Dissaux G, Ollivier L, Goasduff G, Pradier O, et al.
J Contemp Brachytherapy . 2021 Nov; 13(5):541-548. PMID: 34759979
Purpose: Low-dose-rate brachytherapy is a key treatment for low-risk or favorable intermediate-risk prostate cancer. The number of radioactive seeds inserted during the procedure depends on prostate volume, and is not...
12.
Ollivier L, Lucia F, Nguyen T, Lucas C, Bourbonne V, Boussion N, et al.
J Contemp Brachytherapy . 2021 Jan; 12(6):547-553. PMID: 33437302
Purpose: Low-dose-rate brachytherapy (BT) with permanent iodine-125 radioactive seeds is a highly effective treatment option for low- and favorable intermediate-risk prostate cancer. However, optimal implantation is not always achieved due...
13.
Peigne C, Fournier G, Dissaux G, Delage F, Coquet J, Boussion N, et al.
Brachytherapy . 2020 Sep; 20(1):50-57. PMID: 32891570
Purpose: Brachytherapy (BrT) is a standard treatment for low-risk to favorable-intermediate-risk prostate cancer but is a relative contraindication for patients with obstructive symptoms. We aimed to assess the feasibility and...
14.
Schoentgen N, Marolleau J, Delage F, Coquet J, Fourcade A, Callerot P, et al.
J Contemp Brachytherapy . 2019 Aug; 11(3):195-200. PMID: 31435425
Purpose: Prostate brachytherapy (BT) is a validated treatment for localized prostate cancer (CaP) and an attractive therapy option for patients seeking to preserve erectile function (EF). The aim of this...
15.
Chasseray M, Dissaux G, Bourbonne V, Boussion N, Goasduff G, Malloreau J, et al.
Acta Oncol . 2019 Feb; 58(7):1029-1035. PMID: 30761939
To evaluate the occurrence of erectile dysfunction at 3 years (3yED) after prostate brachytherapy (BT) and to predict 3yED after treatment based on patients and treatments characteristics. From September 2007...
16.
Jaouen V, Bert J, Mountris K, Boussion N, Schick U, Pradier O, et al.
IEEE Trans Biomed Eng . 2018 Aug; 66(4):920-933. PMID: 30113888
Objective: We present a new hybrid edge and region-based parametric deformable model, or active surface, for prostate volume segmentation in transrectal ultrasound (TRUS) images. Methods: Our contribution is threefold. First,...
17.
Coquet J, Delage F, Fourcade A, Callerot P, Goasduff G, Boussion N, et al.
Brachytherapy . 2018 Jun; 17(5):782-787. PMID: 29936129
Purpose: "Quadrella" index has been recently developed to assess oncological and functional outcomes after prostate brachytherapy (PB). We aimed to evaluate this index at 1, 2, and 3 years, using...
18.
Fourcade A, Payrard C, Tissot V, Perrouin-Verbe M, Demany N, Serey-Effeil S, et al.
Scand J Urol . 2018 Feb; 52(3):174-179. PMID: 29463177
Objective: Compared with standard systematic transrectal ultrasound (TRUS)-guided biopsies (SBx), targeted biopsies (TBx) using magnetic resonance imaging (MRI)/TRUS fusion could increase the detection of clinically significant prostate cancer (PCa-s) and...
19.
Calves J, Thoulouzan M, Perrouin-Verbe M, Joulin V, Valeri A, Fournier G
Eur Urol Focus . 2017 Nov; 5(4):676-680. PMID: 29102672
Objective: To evaluate the long-term reported clinical outcomes after photovaporization of the prostate (PVP) with the XPS-GreenLight laser in patients with symptomatic benign prostatic enlargement (BPE). Design, Setting, And Participants:...
20.
Hamdan I, Bert J, Rest C, Tasu J, Boussion N, Valeri A, et al.
Med Phys . 2017 Oct; 44(12):6447-6455. PMID: 29044630
Purpose: In prostate radiotherapy, dose distribution may be calculated on CT images, while the MRI can be used to enhance soft tissue visualization. Therefore, a registration between MR and CT...